OTC Markets OTCQB - Delayed Quote USD
BioCorRx Inc. (BICX)
0.2870
0.0000
(0.00%)
As of April 29 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7.6650
7.6650
89.1600
213.8410
48.2720
Cost of Revenue
1.6670
1.6670
35.9860
15.2790
5.8810
Gross Profit
5.9980
5.9980
53.1740
198.5620
42.3910
Operating Expense
3,655.2270
3,655.2270
2,859.9940
3,107.0610
4,575.0940
Operating Income
-3,649.2290
-3,649.2290
-2,806.8200
-2,908.4990
-4,532.7030
Net Non Operating Interest Income Expense
-1,527.5530
-1,527.5530
-886.6270
-1,086.7750
-565.6840
Other Income Expense
-35.3200
-35.3200
-77.0430
-381.5580
-112.2510
Pretax Income
-5,212.1020
-5,212.1020
-3,770.4900
-4,376.8320
-5,210.6380
Net Income Common Stockholders
-5,106.1240
-5,106.1240
-3,766.9130
-4,369.4130
-5,278.3810
Diluted NI Available to Com Stockholders
-5,106.1240
-5,106.1240
-3,766.9130
-4,369.4130
-5,278.3810
Basic EPS
-0.49
--
-0.45
-0.61
-0.81
Diluted EPS
-0.49
--
-0.45
-0.61
-0.81
Basic Average Shares
10,464.3730
--
8,344.0790
7,198.3120
6,491.0670
Diluted Average Shares
10,464.3730
--
8,344.0790
7,198.3120
6,491.0670
Total Operating Income as Reported
-5,122.5050
-5,122.5050
-3,787.7960
-4,697.9950
-5,510.1070
Total Expenses
3,656.8940
3,656.8940
2,895.9800
3,122.3400
4,580.9750
Net Income from Continuing & Discontinued Operation
-5,106.1240
-5,106.1240
-3,766.9130
-4,369.4130
-5,208.2540
Normalized Income
-4,941.5220
-4,941.5220
-3,684.5950
-4,170.4740
-5,066.7740
Interest Expense
1,527.5530
1,527.5530
886.6270
1,086.7750
565.6840
Net Interest Income
-1,527.5530
-1,527.5530
-886.6270
-1,086.7750
-565.6840
EBIT
-3,684.5490
-3,684.5490
-2,883.8630
-3,290.0570
-4,644.9540
EBITDA
-3,589.3000
-3,589.3000
-2,683.9270
-3,148.0920
-4,476.0110
Reconciled Cost of Revenue
1.6670
1.6670
35.9860
15.2790
5.8810
Reconciled Depreciation
95.2490
95.2490
199.9360
141.9650
168.9430
Net Income from Continuing Operation Net Minority Interest
-5,106.1240
-5,106.1240
-3,766.9130
-4,369.4130
-5,208.2540
Total Unusual Items Excluding Goodwill
-164.6020
-164.6020
-82.3180
-198.9390
-141.4800
Total Unusual Items
-164.6020
-164.6020
-82.3180
-198.9390
-141.4800
Normalized EBITDA
-3,424.6980
-3,424.6980
-2,601.6090
-2,949.1530
-4,334.5310
12/31/2021 - 8/31/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade